NL2020159B1 - Method for production of a dairy product and system for composing a dairy product - Google Patents
Method for production of a dairy product and system for composing a dairy product Download PDFInfo
- Publication number
- NL2020159B1 NL2020159B1 NL2020159A NL2020159A NL2020159B1 NL 2020159 B1 NL2020159 B1 NL 2020159B1 NL 2020159 A NL2020159 A NL 2020159A NL 2020159 A NL2020159 A NL 2020159A NL 2020159 B1 NL2020159 B1 NL 2020159B1
- Authority
- NL
- Netherlands
- Prior art keywords
- vitamin
- composition
- dairy product
- product
- total weight
- Prior art date
Links
- 235000013365 dairy product Nutrition 0.000 title claims abstract description 99
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 claims abstract description 154
- 238000000034 method Methods 0.000 claims abstract description 57
- 229940088594 vitamin Drugs 0.000 claims abstract description 51
- 229930003231 vitamin Natural products 0.000 claims abstract description 51
- 235000013343 vitamin Nutrition 0.000 claims abstract description 51
- 239000011782 vitamin Substances 0.000 claims abstract description 51
- 239000008267 milk Substances 0.000 claims abstract description 22
- 210000004080 milk Anatomy 0.000 claims abstract description 22
- 235000013336 milk Nutrition 0.000 claims abstract description 21
- 239000004615 ingredient Substances 0.000 claims abstract description 19
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 12
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 12
- 239000011573 trace mineral Substances 0.000 claims abstract description 10
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 10
- 102000014171 Milk Proteins Human genes 0.000 claims abstract description 8
- 108010011756 Milk Proteins Proteins 0.000 claims abstract description 8
- 235000021239 milk protein Nutrition 0.000 claims abstract description 8
- 239000000047 product Substances 0.000 claims description 33
- 235000013350 formula milk Nutrition 0.000 claims description 32
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 32
- 239000011707 mineral Substances 0.000 claims description 32
- 235000010755 mineral Nutrition 0.000 claims description 32
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 26
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 26
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 26
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 26
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 26
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 26
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 26
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 26
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 25
- 239000008101 lactose Substances 0.000 claims description 25
- 238000002156 mixing Methods 0.000 claims description 21
- 235000016709 nutrition Nutrition 0.000 claims description 21
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 19
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 18
- 229920002472 Starch Polymers 0.000 claims description 18
- 235000019197 fats Nutrition 0.000 claims description 18
- 239000008107 starch Substances 0.000 claims description 18
- 235000019698 starch Nutrition 0.000 claims description 18
- 230000035764 nutrition Effects 0.000 claims description 17
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 16
- 229930003471 Vitamin B2 Natural products 0.000 claims description 16
- 229960002477 riboflavin Drugs 0.000 claims description 16
- 235000019164 vitamin B2 Nutrition 0.000 claims description 16
- 239000011716 vitamin B2 Substances 0.000 claims description 16
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 14
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 14
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 14
- 235000019155 vitamin A Nutrition 0.000 claims description 14
- 239000011719 vitamin A Substances 0.000 claims description 14
- 229940045997 vitamin a Drugs 0.000 claims description 14
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 13
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 13
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 13
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 13
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 13
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 13
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 13
- 229930003268 Vitamin C Natural products 0.000 claims description 13
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 13
- 229930003427 Vitamin E Natural products 0.000 claims description 13
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 13
- 229960002685 biotin Drugs 0.000 claims description 13
- 235000020958 biotin Nutrition 0.000 claims description 13
- 239000011616 biotin Substances 0.000 claims description 13
- 229960001231 choline Drugs 0.000 claims description 13
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 13
- 229910052802 copper Inorganic materials 0.000 claims description 13
- 239000010949 copper Substances 0.000 claims description 13
- 229960000304 folic acid Drugs 0.000 claims description 13
- 235000019152 folic acid Nutrition 0.000 claims description 13
- 239000011724 folic acid Substances 0.000 claims description 13
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 13
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 13
- 229960000367 inositol Drugs 0.000 claims description 13
- 229910052742 iron Inorganic materials 0.000 claims description 13
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 13
- 229960003512 nicotinic acid Drugs 0.000 claims description 13
- 235000001968 nicotinic acid Nutrition 0.000 claims description 13
- 239000011664 nicotinic acid Substances 0.000 claims description 13
- 229940055726 pantothenic acid Drugs 0.000 claims description 13
- 235000019161 pantothenic acid Nutrition 0.000 claims description 13
- 239000011713 pantothenic acid Substances 0.000 claims description 13
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 13
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 13
- 239000011669 selenium Substances 0.000 claims description 13
- 229910052711 selenium Inorganic materials 0.000 claims description 13
- 229960003080 taurine Drugs 0.000 claims description 13
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 13
- 235000019158 vitamin B6 Nutrition 0.000 claims description 13
- 239000011726 vitamin B6 Substances 0.000 claims description 13
- 235000019154 vitamin C Nutrition 0.000 claims description 13
- 239000011718 vitamin C Substances 0.000 claims description 13
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 13
- 235000005282 vitamin D3 Nutrition 0.000 claims description 13
- 239000011647 vitamin D3 Substances 0.000 claims description 13
- 235000019165 vitamin E Nutrition 0.000 claims description 13
- 239000011709 vitamin E Substances 0.000 claims description 13
- 229940046009 vitamin E Drugs 0.000 claims description 13
- 229940011671 vitamin b6 Drugs 0.000 claims description 13
- 229940021056 vitamin d3 Drugs 0.000 claims description 13
- 239000011701 zinc Substances 0.000 claims description 13
- 229910052725 zinc Inorganic materials 0.000 claims description 13
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 11
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 11
- 239000011630 iodine Substances 0.000 claims description 11
- 229910052740 iodine Inorganic materials 0.000 claims description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 10
- 229920000881 Modified starch Polymers 0.000 claims description 10
- 229930003451 Vitamin B1 Natural products 0.000 claims description 10
- 239000012876 carrier material Substances 0.000 claims description 10
- 239000008103 glucose Substances 0.000 claims description 10
- 235000019426 modified starch Nutrition 0.000 claims description 10
- 229960003495 thiamine Drugs 0.000 claims description 10
- 235000010374 vitamin B1 Nutrition 0.000 claims description 10
- 239000011691 vitamin B1 Substances 0.000 claims description 10
- 235000020247 cow milk Nutrition 0.000 claims description 7
- 235000020251 goat milk Nutrition 0.000 claims description 7
- 229930006000 Sucrose Natural products 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- 230000001419 dependent effect Effects 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- 229930003779 Vitamin B12 Natural products 0.000 claims description 5
- 235000013305 food Nutrition 0.000 claims description 5
- 235000019163 vitamin B12 Nutrition 0.000 claims description 5
- 239000011715 vitamin B12 Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 229920002774 Maltodextrin Polymers 0.000 claims description 4
- 239000005913 Maltodextrin Substances 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- 229940035034 maltodextrin Drugs 0.000 claims description 4
- 230000008774 maternal effect Effects 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 235000020209 toddler milk formula Nutrition 0.000 claims description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- 229920002261 Corn starch Polymers 0.000 claims description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- 229930195725 Mannitol Natural products 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 239000008120 corn starch Substances 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 239000000594 mannitol Substances 0.000 claims description 3
- 235000010355 mannitol Nutrition 0.000 claims description 3
- 235000012054 meals Nutrition 0.000 claims description 3
- 238000011084 recovery Methods 0.000 claims description 3
- 239000013589 supplement Substances 0.000 claims description 3
- -1 L-camitine Chemical compound 0.000 claims description 2
- 235000020218 follow-on milk formula Nutrition 0.000 claims description 2
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 229960004203 carnitine Drugs 0.000 claims 1
- 239000002131 composite material Substances 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Substances [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims 1
- 239000003925 fat Substances 0.000 description 15
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 238000012545 processing Methods 0.000 description 6
- 239000006188 syrup Substances 0.000 description 5
- 235000020357 syrup Nutrition 0.000 description 5
- 241000283707 Capra Species 0.000 description 4
- 108010046377 Whey Proteins Proteins 0.000 description 4
- 102000007544 Whey Proteins Human genes 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 241001416153 Bos grunniens Species 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 241000282836 Camelus dromedarius Species 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 235000008504 concentrate Nutrition 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 235000019871 vegetable fat Nutrition 0.000 description 3
- 235000021119 whey protein Nutrition 0.000 description 3
- 239000005905 Hydrolysed protein Substances 0.000 description 2
- 102220547770 Inducible T-cell costimulator_A23L_mutation Human genes 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 238000012356 Product development Methods 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000005862 Whey Substances 0.000 description 1
- 238000009455 aseptic packaging Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000008131 children development Effects 0.000 description 1
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 238000013068 supply chain management Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/06—Mixtures of whey with milk products or milk components
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/158—Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Pediatric Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
Abstract
Description
OctrooicentrumPatent center
Θ 2020159Θ 2020159
(2?) Aanvraagnummer: 2020159 (22) Aanvraag ingediend: 22 december 2017(2?) Application number: 2020159 (22) Application submitted: December 22, 2017
Int. Cl.:Int. Cl .:
A23C 9/152 (2018.01) A23C 9/158 (2018.01) A23LA23C 9/152 (2018.01) A23C 9/158 (2018.01) A23L
33/15 (2018.01) A23L 33/16 (2018.01)33/15 (2018.01) A23L 33/16 (2018.01)
METHOD FOR PRODUCTION OF A DAIRY PRODUCT AND SYSTEM FOR COMPOSING A DAIRY PRODUCT © The present invention relates to a method for production of a dairy product. More specifically, in the method of present invention base elements of milk, such as fat, carbohydrates milk proteins are mixed with multiple predetermined mixtures comprising vitamins and trace minerals and optionally additional ingredients. Furthermore, the present invention relates to a system for composing a dairy product using the method of present invention.METHOD FOR PRODUCTION OR A DAIRY PRODUCT AND SYSTEM FOR COMPOSING A DAIRY PRODUCT © The present invention relates to a method of production of a dairy product. More specifically, in the method of present invention base elements of milk, such as fat, carbohydrates milk proteins are mixed with multiple predetermined mixtures including vitamins and trace minerals and optionally additional ingredients. Furthermore, the present invention relates to a system for composing a dairy product using the method of present invention.
NL B1 2020159NL B1 2020159
Dit octrooi is verleend ongeacht het bijgevoegde resultaat van het onderzoek naar de stand van de techniek en schriftelijke opinie. Het octrooischrift komt overeen met de oorspronkelijk ingediende stukken.This patent has been granted regardless of the attached result of the research into the state of the art and written opinion. The patent corresponds to the documents originally submitted.
METHOD FOR PRODUCTION OF A DAIRY PRODUCT AND SYSTEM FOR COMPOSING A DAIRY PRODUCTMETHOD FOR PRODUCTION OR A DAIRY PRODUCT AND SYSTEM FOR COMPOSING A DAIRY PRODUCT
The present invention relates to a method for production of a dairy product. More specifically, in the method of present invention base elements of milk, such as fat, carbohydrates milk proteins are mixed with multiple predetermined mixtures comprising vitamins and trace minerals and optionally additional ingredients. Furthermore, the present invention relates to a system for composing a dairy product using the method of present invention.The present invention relates to a method for production or a dairy product. More specifically, in the method of present invention base elements of milk, such as fat, carbohydrates milk proteins are mixed with multiple predetermined mixtures including vitamins and trace minerals and optionally additional ingredients. Furthermore, the present invention relates to a system for composing a dairy product using the method of present invention.
There are three main processes in the industry for the production of dairy products, more specifically infant formula. These are integral spray drying, semi-integral spray drying and dry blending, of which dry blending is the most commonly used. Dry blending is an operation in infant formula manufacturing, wherein individual powdered components (amongst others an infant formula base powder) comprising the various ingredients are blended and subsequently mixed with vitamin- and minerals powdered components.There are three main processes in the industry for the production of dairy products, more specifically the infant formula. These are integral spray drying, semi-integral spray drying and dry blending, or which dry blending is the most commonly used. Dry blending is an operation in infant formula manufacturing, including individual powdered components (among others an infant formula base powder) including the various ingredients are blended and subsequently mixed with vitamin and minerals powdered components.
An infant formula base powder or milk product comprises of at least milk, protein, fat and carbohydrates. The production process starts with the main ingredient being milk, e.g., goat, cow, sheep, camel, yak, soy milk, a milk protein source (such as whey protein) from goat, cow, sheep, camel, yak, soy, or a (enzymatically) hydrolysed protein source, and a fat source being a vegetable fat blend, a structured lipid such as OPO, or fat from mammal milk origin or a combination thereof, and a carbohydrate source, such as, lactose, a hydrolysed starch derivate such as maltodextrin or glucose syrup, potato- or com starch, in liquid or powder state. The mixture will be first pasteurized, followed by evaporation, and subsequently spray dried to obtain for instance an infant formula base powder. These methods for production of an infant formula are well known in the art.An infant formula base powder or milk product includes or at least milk, protein, fat and carbohydrates. The production process starts with the main ingredient being milk, eg, goat, cow, sheep, camel, yak, soy milk, a milk protein source (such as whey protein) from goat, cow, sheep, camel, yak, soy, or a (enzymatically) hydrolysed protein source, and a fat source being a vegetable fat blend, a structured lipid such as OPO, or fat from mammal milk origin or a combination thereof, and a carbohydrate source, such as, lactose, a hydrolysed starch derivate such as maltodextrin or glucose syrup, potato or com starch, in liquid or powder state. The mixture will be first pasteurized, followed by evaporation, and subsequent spray three to obtain for an infant formula base powder. These methods for production or an infant formula are well known in the art.
The difference between cow and human milk are amongst others the quantities of lactose, proteins, minerals and fat. Also the compositions and bioavailability of proteins, minerals and fat are different. In order to produce a mammalian milk (not being human milk) suitable for consumption by human infants, the protein, fat, mineral and vitamin content requires adjustments. Since there are various infant formulas available on the market, with each infant formula having their own composition that differs from one another, the amount of ingredients, fats vitamins and minerals that need to be added to the base powder during the production process may also strongly differ.The difference between cow and human milk are among others the quantities of lactose, proteins, minerals and fat. Also the compositions and bioavailability of proteins, minerals and fat are different. In order to produce a mammalian milk (not being human milk) suitable for consumption by human infants, the protein, fat, mineral and vitamin content requires adjustments. Since there are various infant formula available on the market, with each infant formula having their own composition that differs from one, the amount of ingredients, vitamins and minerals that need to be added to the base powder during the production process may also strongly differ.
Infant formula manufacturers often have a hard time managing their inventory, more specifically managing stock keeping units, which can easily range above one hundred, up to several hundreds of recipes, leading to a complex storage management. Furthermore, enabling the development and production of all these recipes requires complex and laborious operation. For product development, each different recipe requires a full product development cycle, including recipe calculations, and all need to be checked individually against prevalent, local legislation and meet local nutritional requirements. For procurement, all different product composition demand a large array of ingredients that need to be purchased, managed and of which availability has to be secured and checked by quality control prior to production. For production it means that many different recipes/prodncl imply short productions runs, which makes it more difficult to have stable production runs, which leads to the challenge to obtain a product that is always within specification and compliant with (food) legislation per jurisdiction (e.g. EU, US, etc). In addition, the use of many stock keeping units also means more frequent cleaning of the production and processing lines, resulting in more downtime.Infant formula manufacturers often have a hard time managing their inventory, more specifically managing stock keeping units, which can easily range above one hundred, up to several hundreds of recipes, leading to a complex storage management. Furthermore, enabling the development and production of all these recipes requires complex and laborious operation. For product development, each different recipe requires a full product development cycle, including recipe calculations, and all need to be checked against prevalent, local legislation and meet local nutritional requirements. For procurement, all different product composition demand a large array of ingredients that need to be purchased, managed and or which availability has been secured and checked by quality control prior to production. For production it means that many different recipes / prodncl imply short productions runs, which makes it more difficult to have stable production runs, which leads to the challenge to obtain a product that is always within specification and compliant with (food) legislation per jurisdiction ( eg EU, US, etc). In addition, the use of many stock keeping units also means more frequent cleaning of the production and processing lines, resulting in more downtime.
It is an object of the present invention, amongst other objects, to address the above need in the art. The object of present invention, amongst other objects, is met by the present invention as outlined in the appended claims.It is an object of the present invention, among other objects, to address the above need in the art. The object of present invention, among other objects, is with the present invention as outlined in the appended claims.
Specifically, the above object, amongst other objects, is met, according to a first aspect, by the present invention by a method for production of a dairy product, wherein the method is comprised of the steps of:Specifically, the above object, among other objects, is with, according to a first aspect, by the present invention by a method for production of a dairy product, according to the method is comprised of the steps of:
a) providing a mixture of base elements of said dairy product, wherein said base elements are milk, fat, carbohydrates, and optionally additional milk protein and water- and/or fat soluble ingredients;a) providing a mixture of base elements or said dairy product, said said base elements are milk, fat, carbohydrates, and optionally additional milk protein and water and / or fat soluble ingredients;
b) providing a composition A comprising vitamins, a composition B comprising trace minerals, and a composition C comprising at least 5% - 35% potassium, based on the total weight of the composition C;b) providing a composition including vitamins, a composition containing trace minerals, and a composition comprising at least 5% - 35% potassium, based on the total weight of the composition C;
c) mixing of the compositions A, B and C to obtain the dairy product, wherein the amount of the vitamins and minerals in said compositions A and B, and the amount of C used in the mix depend on if said dairy product is a goat milk based product or a cow milk based product.c) mixing the compositions A, B and C to obtain the dairy product, the amount of vitamins and minerals in said compositions A and B, and the amount of C used in the mix depend on if said dairy product is a goat milk based product or a cow milk based product.
The present invention provides a method for the production of a dairy product, wherein the various components and their compositions of a (e.g. dry blended) dairy product, more preferably an infant formula, are calculated and prepared to match and be compatible in order to be combined optimally to deliver the desired products within specifications of the food product.The present invention provides a method for the production of a dairy product, the various components and their compositions of a (eg dry blended) dairy product, more preferably an infant formula, are calculated and prepared to match and are compatible in order to be combined optimally to deliver the desired products within specifications of the food product.
According to the invention, the dairy product is comprised of at least milk of mammalian origin (but not human), enriched with fat and carbohydrates. The milk may also be a protein source from milk. Optionally, an additional milk protein source (such as whey protein) from goat, cow, sheep, camel, yak, soy, or a (enzymatically) hydrolysed protein source can be added as base element to the mixture of step a. The fat source can be a vegetable fat and/or oil (blend) or fat from mammal milk origin or a combination thereof. The carbohydrate source can be lactose, maltodextrin, potato- or com starch.According to the invention, the dairy product is comprised of milk or mammalian origin (but not human), enriched with fat and carbohydrates. The milk may also be a protein source from milk. Optionally, an additional milk protein source (such as whey protein) from goat, cow, sheep, camel, yak, soy, or a (enzymatically) hydrolysed protein source can be added as a base element to the mixture or step a. The fat source can be a vegetable fat and / or oil (blend) or fat from mammal milk origin or a combination thereof. The carbohydrate source can be lactose, maltodextrin, potato or com starch.
According to another preferred embodiment, the present invention relates to the method, wherein in step c) the mixing of the compositions A, B and C is to obtain the dairy product, wherein the amount of the vitamins and minerals in said compositions A and B, and the amount of C used in the mix further depend on the type of product being manufactured. Different requirements are needed for dairy product supporting the different stages in infant development, e.g. infant formula suitable for infants of 0-6 months, follow-up formula suitable for infants of 6-12 months, and growing up milk suitable for infants of 12-36 months of age.According to another preferred embodiment, the present invention relates to the method, in step c) the mixing of the compositions A, B and C is available in the dairy product, in the amount of vitamins and minerals in said compositions A and B , and the amount of C used in the mix further dependent on the type of product being manufactured. Different requirements are needed for dairy product supporting the different stages in infant development, eg infant formula suitable for infants of 0-6 months, follow-up formula suitable for infants of 6-12 months, and growing up milk suitable for infants of 12- 36 months of age.
According to yet another preferred embodiment, the present invention relates to the method, wherein wherein in step c) the mixing of the compositions A, B and C is to obtain the dairy product, wherein the amount of the vitamins and minerals in said compositions A and B, and the amount of C used in the mix further depend on local regulatory requirements on nutritional product composition.According to yet another preferred embodiment, the present invention relates to the method, according to in step c) the mixing of the compositions A, B and C is to obtain the dairy product, the amount of the vitamins and minerals in said compositions A and B, and the amount of C used in the mix further dependent on local regulatory requirements on nutritional product composition.
In the method of present invention there may be a difference in composition A, B and C when producing a dairy product based on goat/cow milk, the dairy product also may need to differ is specification/content due to the different legislation in respect to food products in for instance Europe in comparison to other parts of the world (Global - Codex). This thus means that the amount of composition A, B and C to be used for the production of a specific dairy product may differ because it needs to comply with legislation per j urisdiction.In the method of present invention there may be a difference in composition A, B and C when producing a dairy product based on goat / cow milk, the dairy product also may need to differ specification / content due to the different legislation in respect to food products in for instance Europe in comparison to other parts of the world (Global - Codex). This thus means that the amount of composition A, B and C to be used for the production of a specific dairy product may differ because it needs to comply with legislation per j urisdiction.
The method of present invention drastically reduces the number of stock keeping units, i.e. using pre-mixes (or pre-blends) comprised of vitamins, trace minerals and minerals, while remaining the potential to produce a large number of different dairy products from these units. Depending on the ratio/portions of composition A, B and C, a great variety of different dairy products are obtained from only a limited number of stock keeping units. Furthermore, the method of present invention is beneficial for stability-vulnerable ingredients, such as vitamins. In addition, keeping vitamins and minerals separated as long as possible in a separate pre-mix is beneficial for product stability; and is therefore preferred over having pre-mixes wherein vitamins and minerals are combined.The method of present invention drastically reduces the number of stock keeping units, ie using pre-mixes (or pre-blends) comprised of vitamins, trace minerals and minerals, while remaining the potential to produce a large number of different dairy products from these units . Depending on the ratio / portions of composition A, B and C, a great variety of different dairy products are obtained from only a limited number of stock keeping units. Furthermore, the method of present invention is beneficial for stability-vulnerable ingredients, such as vitamins. In addition, keeping vitamins and minerals separated as long as possible in a separate pre-mix is beneficial for product stability; and is therefore preferred about having pre-mixes vitamins and minerals are combined.
The method of present invention has the advantage for the final product to shorten the time-to-market due to limitation of the variation within recipes, and less considerations regarding the use of separate ingredients. Dosing in the final product is more precise because a larger amount of the premixes are added, instead of small portions of individual ingredients and components. The method is more cost effective due to the limited number of different base powders and premix recipes. Because variation within recipes and pre-blends is limited, there will be a reduction in analytical costs in batch test and release of the finished product. It will also enable stock production of micronutrient pre-blends resulting in less stock keeping units, less storage, lower procurement costs, thereby creating more flexibility in supply chain management. The method of present invention will result in that there will be less down-time of the production facility because of cleaning of the production machines and that fewer cleaning steps can be involved.The method of present invention has the advantage for the final product to shorten the time-to-market due to limitation of variation within recipes, and fewer considerations regarding the use of separate ingredients. Dosing in the final product is more precise because a larger amount of the premixes are added, instead of small portions or individual ingredients and components. The method is more cost effective due to the limited number of different base powders and premix recipes. Because variation within recipes and pre-blends is limited, there will be a reduction in analytical costs in batch test and release of the finished product. It will also enable stock production or micronutrient pre-blending resulting in less stock keeping units, less storage, lower procurement costs, creating more flexibility in supply chain management. The method of present invention will result in that there will be less down-time of the production facility because of cleaning of the production machines and that fewer cleaning steps can be involved.
According to a preferred embodiment, the present invention relates to the method, wherein the composition A is comprised of 10% - 30% choline, 0.5% - 2.5% niacin, 2% - 15% taurine, 5% - 25% vitamin C, 4% - 10% hydrolysed starch derivate or lactose, 0.5% - 2.5% vitamin E, 0.001% - 0.1% vitamin D3, 0.01% - 0.5% vitamin A, 0.01% - 2.5% L-camitine, 0.2% - 1% pantothenic acid, 0.1% - 7.5% inositol, 0.001% -0.2% biotin, 0.01% - 0.2% folic acid, 0.001% 0.2% vitamin KI, 0.01% - 0.5% vitamin Bl, 0.01% - 0.5% vitamin B2, 0.01% - 0.5% vitamin B6, and 0.00001% - 0.2% vitamin B12„ based on the total weight of the composition A.According to a preferred embodiment, the present invention relates to the method, according to the composition A is comprised of 10% - 30% choline, 0.5% - 2.5% niacin, 2% - 15% taurine, 5% - 25% vitamin C, 4% - 10% hydrolysed starch derivate or lactose, 0.5% - 2.5% vitamin E, 0.001% - 0.1% vitamin D3, 0.01% - 0.5% vitamin A, 0.01% - 2.5% L-camitine, 0.2% - 1% pantothenic acid, 0.1% - 7.5% inositol, 0.001% -0.2% biotin, 0.01% - 0.2% folic acid, 0.001% 0.2% vitamin KI, 0.01% - 0.5% vitamin B1, 0.01% - 0.5% vitamin B2, 0.01% - 0.5% vitamin B6, and 0.00001% - 0.2% vitamin B12 "based on the total weight of the composition A.
According to another preferred embodiment, the present invention relates to the method, wherein the composition B is comprised of 0.1% - 4% iron, 0.5% - 2.5% zinc, 0.01% - 1% manganese, 1% - 7% hydrolysed starch derivate or lactose , 0.1% - 1% copper, 0.01% - 1% iodine and 0.001%- 1% selenium, based on the total weight of said composition B.According to another preferred embodiment, the present invention relates to the method, according to the composition B is comprised of 0.1% - 4% iron, 0.5% - 2.5% zinc, 0.01% - 1% manganese, 1% - 7% hydrolysed starch derivate or lactose, 0.1% - 1% copper, 0.01% - 1% iodine and 0.001% - 1% selenium, based on the total weight of said composition B.
According to yet another preferred embodiment, the present invention relates to the method, wherein said composition C is further comprised of at most 35% calcium, at most 20% phosphorous, at most 5% magnesium, at most 30% hydrolysed starch derivate or lactose, at most 10% sodium and at most 20% chloride, based on the total weight of said composition C.According to yet another preferred embodiment, the present invention relates to the method, said said composition C is further comprised of at most 35% calcium, at most 20% phosphorous, at most 5% magnesium, at most 30% hydrolysed starch derivate or lactose , at most 10% sodium and at most 20% chloride, based on the total weight of said composition C.
According to another preferred embodiment, the present invention relates to the method, further comprising the step of determining the amount of composition A, composition B, and composition C to be mixed in order to obtain the dairy product that corresponds with a dairy product content specification. In case the dairy product is a product for the EU market, the composition C comprising the minerals as indicated above, is present in the dairy product due to food legislation in the EU.According to another preferred embodiment, the present invention relates to the method, further comprising the step of determining the amount of composition A, composition B, and composition C to be mixed in order to obtain the dairy product that corresponds with a dairy product content specification . In case the dairy product is a product for the EU market, the composition C including the minerals as indicated above, is present in the dairy product due to food legislation in the EU.
According to a preferred embodiment, the present invention relates to the method, wherein in case the dairy product is a goat milk based product, the composition A is comprised of about 25% choline, about 0.7% niacin, about 5% taurine, about 7% vitamin C, about 5% hydrolysed starch derivate or lactose, about 1% vitamin E, about 0.02% vitamin D3, about 0.1% vitamin A, about 1.4% L-carnitine, about 0.5% pantothenic acid, about 4.5% inositol, about 0.002% biotin, about 0.015% folic acid, about 0.01% vitamin KI, about 0.1% vitamin Bl, about 0.1% vitamin B2, about 0.05% vitamin B6, and 0.0002% vitamin Bl2, based on the total weight of the composition A, and wherein the composition B is comprised of 0.1% - 4% iron, 0.5% - 2.5% zinc, 0.01% - 1% manganese, 1% - 7% hydrolysed starch derivate or lactose, 0.1% - 1% copper, 0.01% - 1% iodine and 0.001% - 1% selenium, based on the total weight of said composition B.According to a preferred embodiment, the present invention relates to the method, in in case the dairy product is a goat milk based product, the composition A is comprised of about 25% choline, about 0.7% niacin, about 5% taurine, about 7 % vitamin C, about 5% hydrolyzed starch derivative or lactose, about 1% vitamin E, about 0.02% vitamin D3, about 0.1% vitamin A, about 1.4% L-carnitine, about 0.5% pantothenic acid, about 4.5% inositol, about 0.002% biotin, about 0.015% folic acid, about 0.01% vitamin KI, about 0.1% vitamin B1, about 0.1% vitamin B2, about 0.05% vitamin B6, and 0.0002% vitamin B2, based on the total weight of the composition A, B is comprised of 0.1% - 4% iron, 0.5% - 2.5% zinc, 0.01% - 1% manganese, 1% - 7% hydrolysed starch derivate or lactose, 0.1% - 1% copper, 0.01% - 1% iodine and 0.001% - 1% selenium, based on the total weight of said composition B.
According to yet another preferred embodiment, the present invention relates to the method, wherein the dairy product is a cow milk based product, the composition A is comprised of 12% to 26% choline, 0.5% - 2% niacin, 5% - 12.5% taurine, 5% - 25% vitamin C, 6% - 9% hydrolysed starch derivate or lactose, 1% - 2.5% vitamin E, 0.001% - 0.005% vitamin D3, 0.1% 0.25% vitamin A, 0.01% - 2% L-carnitine, 0.2% - 1% pantothenic acid, 0.2% - 2% inositol, 0.001% -0.1% biotin, 0.01% - 0.1% folic acid, 0.05% - 0.5% vitamin KI, 0.01% - 0.5% vitamin Bl, 0.01% - 0.5% vitamin B2, 0.01% - 0.5% vitamin B6, and 0.00001% - 0.2% vitamin B12, based on the total weight of the composition A, and wherein the composition B is comprised of 0.1% 4% iron, 0.5% - 2.5% zinc, 0.01% - 1% manganese, 1% - 7% hydrolysed starch derivate or lactose , 0.1% - 1% copper, 0.01% - 1% iodine and 0.001% - 1% selenium, based on the total weight of said composition B.According to yet another preferred embodiment, the present invention relates to the method, according to the dairy product is a cow milk based product, the composition A is comprised or 12% to 26% choline, 0.5% - 2% niacin, 5% - 12.5 % taurine, 5% - 25% vitamin C, 6% - 9% hydrolysed starch derivate or lactose, 1% - 2.5% vitamin E, 0.001% - 0.005% vitamin D3, 0.1% 0.25% vitamin A, 0.01% - 2% L-carnitine, 0.2% - 1% pantothenic acid, 0.2% - 2% inositol, 0.001% -0.1% biotin, 0.01% - 0.1% folic acid, 0.05% - 0.5% vitamin KI, 0.01% - 0.5% vitamin Bl, 0.01% - 0.5% vitamin B2, 0.01% - 0.5% vitamin B6, and 0.00001% - 0.2% vitamin B12, based on the total weight of the composition A, and including the composition B is comprised of 0.1% 4% iron, 0.5 % - 2.5% zinc, 0.01% - 1% manganese, 1% - 7% hydrolysed starch derivate or lactose, 0.1% - 1% copper, 0.01% - 1% iodine and 0.001% - 1% selenium, based on the total weight or said composition B.
According to another preferred embodiment, the present invention relates to the method, wherein vitamins and/or minerals are encapsulated with a carrier material, wherein the carrier material is selected from the group consisting of a hydrolysed starch derivate, sucrose, starch, mannitol, or a mixture of corn starch and sucrose, preferably glucose or glucose syrup solids. The compositions comprised of (trace) minerals, vitamins can be prepared by encapsulation or immobilization of the sensitive nutrients, stability-vulnerable ingredients on a carrier material, in order to protect these ingredients and separated them from each other by means of this encapsulation, to avoid or prevent degradation or oxidation and thereby loosing their nutritional value. Sensitive nutrients can be for example vitamins or minerals that are vulnerable towards oxidation, degradation, etc.According to another preferred embodiment, the present invention relates to the method, vitamins and / or minerals are encapsulated with a carrier material, the carrier material is selected from the group consisting of a hydrolysed starch derivate, sucrose, starch, mannitol, or a mixture of corn starch and sucrose, preferably glucose or glucose syrup solids. The compositions comprised of (trace) minerals, vitamins can be prepared by encapsulation or immobilization of the sensitive nutrients, stability-vulnerable ingredients on a carrier material, in order to protect these ingredients and separated them from each other by means of this encapsulation, to avoid or prevent degradation or oxidation and loosing their nutritional value. Sensitive nutrients can be example vitamins or minerals that are vulnerable towards oxidation, degradation, etc.
According to a preferred embodiment, the present invention relates to the method, wherein the encapsulated mineral is one or more selected from the group consisting of iron, zinc, manganese, copper, iodine and selenium.According to a preferred embodiment, the present invention relates to the method, the encapsulated mineral is one or more selected from the group consisting of iron, zinc, manganese, copper, iodine and selenium.
According to yet another preferred embodiment, the present invention relates to the method, wherein the encapsulated vitamin is one or more selected from the group consisting of choline, niacin, taurine, vitamin C, vitamin E, vitamin D3, vitamin A, L-carnitine, pantothenic acid, inositol, biotin, folic acid, vitamin KI, vitamin Bl, vitamin B2, vitamin B6, and vitamin Bl2. Encapsulated vitamins as indicated above have the advantage it result in an improved homogeneity and stability of these vitamins in the composition of present invention.According to yet another preferred embodiment, the present invention relates to the method, according to the encapsulated vitamin is one or more selected from the group consisting of choline, niacin, taurine, vitamin C, vitamin E, vitamin D3, vitamin A, L-carnitine , pantothenic acid, inositol, biotin, folic acid, vitamin A, vitamin B1, vitamin B2, vitamin B6, and vitamin B2. Encapsulated vitamins as indicated above have the advantage it results in an improved homogeneity and stability of these vitamins in the composition of the present invention.
According to a preferred embodiment, the present invention relates to the method, wherein the compositions A, B and C are powders.According to a preferred embodiment, the present invention relates to the method, according to the compositions A, B and C are powders.
The present invention, according to a second aspect, relates to a dairy product obtained according to the method of present invention.The present invention, according to a second aspect, relates to a dairy product obtained according to the method of present invention.
According to a preferred embodiment, the present invention relates to the dairy product, wherein the dairy product is a dry powder or a liquid, wherein the product is selected from the group consisting of an infant formula, follow-on formula, growing-up milk, children’s nutrition, maternal nutrition, elderly nutrition, sports- and performance nutrition, recovery nutrition, supplements, meal replacers, and clinical nutrition, preferably an infant formula. Additional products could be envisaged for groups of consumers with specific needs, not limited to performance nutrition for amateur and professional athletes, maternal nutrition, elderly nutrition, and clinical nutrition. Such products are commonly available as instant powder, to be dissolved in warm water prior to consumption. For example, a liquid milk formula based on the composition of present invention can be obtained by dissolving of dry powder of the composition in water. The dairy product can also be a ready-to-feed liquid formulation, packed in an aseptic packaging, such as an aseptic pouch or aseptic bottle. As alternative, sterilized, ready-to-drink formula (sold as liquid) is another possible dairy product format.According to a preferred embodiment, the present invention relates to the dairy product, where the dairy product is a dry powder or a liquid, if the product is selected from the group consisting of an infant formula, follow-on formula, growing-up milk , children's nutrition, maternal nutrition, elderly nutrition, sports and performance nutrition, recovery nutrition, supplements, meal replacers, and clinical nutrition, preferably an infant formula. Additional products could be envisaged for groups of consumers with specific needs, not limited to performance nutrition for amateur and professional athletes, maternal nutrition, elderly nutrition, and clinical nutrition. Such products are commonly available as instant powder, dissolved in hot water prior to consumption. For example, a liquid milk formula based on the composition of present invention can be obtained by dissolving or dry powder or the composition in water. The dairy product can also be a ready-to-feed liquid formulation, packed in an aseptic packaging, such as an aseptic pouch or aseptic bottle. As an alternative, sterilized, ready-to-drink formula (sold as liquid) is another possible dairy product format.
The present invention, according to a third aspect, relates to a system for composing a dairy product, wherein the system is comprised of a number of containers for holding composition A, composition B and composition C, a mixing device that is operatively connected to the containers for mixing the compositions A, B and C into a determined dairy product composition, wherein the system further comprises an output configured for supplying a composed diary product, an input configured for receiving a dairy product order, a processor that is connected to the input and configured for determining said dairy product composition of the received dairy product order, wherein the dairy product composition comprises a composition A comprising vitamins, a composition B comprising trace minerals, and a composition C comprising minerals.The present invention, according to a third aspect, relates to a system for composing a dairy product, requiring the system is comprised of a number of containers for holding composition A, composition B and composition C, a mixing device that is operatively connected to the containers for mixing the compositions A, B and C into a determined dairy product composition, in which the system further comprises an output configured for supplying a composed diary product, an input configured for receiving a dairy product order, a processor that is connected to the input and configured for determining said dairy product composition of the received dairy product order, containing the dairy product composition comprising a composition A including vitamins, a composition containing trace minerals, and a composition containing minerals.
Further advantages, features and details of the invention are elucidated on the basis of preferred embodiments thereof, wherein reference is made to the accompanying drawings, in which:Further advantages, features and details of the invention are elucidated on the basis or preferred otherwise, where reference is made to the accompanying drawings, in which:
- Fig. 1: Shows an embodiment of the method of present invention.FIG. 1: Shows an embodiment of the method of present invention.
Production process 2 (Fig. 1) of a dairy product according to an embodiment of the method of present invention starts with the supply of fresh milk 4. In the illustrated embodiment, in the first processing sub-stage 1, the milk is first pasteurized 8, and optionally cream 10 is separated in separation step 12. Evaporation step 14 results in (skimmed) milk concentrate 16.Production process 2 (Fig. 1) or a dairy product according to an embodiment of the method of present invention starts with the supply of fresh milk 4. In the illustrated edition, in the first processing sub-stage 1, the milk is first pasteurized 8, and optionally cream 10 is separated in separation step 12. Evaporation step 14 results in (skimmed) milk concentrate 16.
In second processing sub-stage 11, concentrate 16 can optionally be provided with water soluble ingredients 18, such as protein, carbohydrates and/or minerals and/or can optionally be provided with fat-soluble ingredients 20, such as milk and/or vegetable fat, fat soluble vitamins. This results in a product that is comprised of base elements (milk and/or a protein source from milk, fat carbohydrates) and optionally added ingredients such as additional protein, minerals and/or processing agents, for example. After (wet) blending 22, the mixture will be pasteurized 24, homogenized 26, and subsequently spray dried 28 to obtain an infant formula base powder 30.In second processing sub-stage 11, concentrate 16 can optionally be provided with water-soluble ingredients 18, such as protein, carbohydrates and / or minerals and / or can optionally be provided with fat-soluble ingredients 20, such as milk and / or vegetable fat, fat soluble vitamins. This results in a product that is comprised of basic elements (milk and / or a protein source from milk, fat carbohydrates) and optionally added ingredients such as additional protein, minerals and / or processing agents, for example. After (wet) blending 22, the mixture will be pasteurized 24, homogenized 26, and further spray dried 28 to obtain an infant formula base powder 30.
Next, in the illustrated embodiment of the present invention in third processing sub-stage III, building blocks A, B and C 32a, 32b, 32c are added to the dairy product mixture to obtain the final dairy product that corresponds with the dairy product content specification. Optionally, additional complementary ingredients 34 can be added to the product. After (dry) blending 36 the intended finished product 38 is produced. It will be understood that alternative and/or additional (sub)-processing steps can be envisaged in conformity with the present invention.Next, in the illustrated embodiment of the present invention in third processing sub-stage III, building blocks A, B and C 32a, 32b, 32c are added to the dairy product mixture to obtain the final dairy product that is agreed with the dairy product content specification. Optionally, additional complementary ingredients 34 can be added to the product. After (dry) blending 36 the intended finished product 38 is produced. It will be understood that alternative and / or additional (sub) processing steps can be envisaged in conformity with the present invention.
Example - stage 1 infant formula (0-6 months) for the European market (compliant EU legislation)Example - stage 1 infant formula (0-6 months) for the European market (compliant EU legislation)
A stage 1 infant formula dairy product suitable for infants up to six months is produced according to the method of present invention.A stage 1 infant formula dairy product suitable for infants up to six months is produced according to the method of present invention.
An infant formula base making up about 92.5 wt% based on the total weight of the dairy product, the infant formula base is composed of 30 - 50% demineralized whey powder, 20 30% vegetable oils, 10-30 % lactose, 5 - 20% skimmed milk, 0 - 5% whey protein concentrate, and 0 - 2% minerals. The infant formula based is mixed with;An infant formula base making up about 92.5 wt% based on the total weight of the dairy product, the infant formula base is composed of 30 - 50% demineralized whey powder, 20 30% vegetable oils, 10-30% lactose, 5 - 20 % skimmed milk, 0 - 5% whey protein concentrate, and 0 - 2% minerals. The infant formula based is mixed with;
About 0.42 wt% of Building Block A based on the total weight of the dairy product, composed of 23.2% choline, 1.03% niacine, 9.6% taurine, 8.3% glucose syrup solids, 7.61 % vitamin C, 0.003% vitamin D3, 0.52% vitamin E, 0.11% vitamin A, 0.46% L-carnitine, 0.55% pantothenic acid, 0.5% inositol, 0.003% biotin, 0.018% folic acid, 0.008% vitamin KI, 0.09% vitamin Bl, 0.10% vitamin B2, 0.08% vitamin B6, 0.0001% vitamin Bl2, the remainder being comprised of counter ions (in case the nutrients are added as salts) and/or carrier materials.About 0.42 wt% of Building Block A based on the total weight of the dairy product, composed of 23.2% choline, 1.03% niacin, 9.6% taurine, 8.3% glucose syrup solids, 7.61% vitamin C, 0.003% vitamin D3, 0.52% vitamin E, 0.11% vitamin A, 0.46% L-carnitine, 0.55% pantothenic acid, 0.5% inositol, 0.003% biotin, 0.018% folic acid, 0.008% vitamin KI, 0.09% vitamin B1, 0.10% vitamin B2, 0.08% vitamin B6, 0.0001% vitamin Bl2, the remainder being comprised of counter ions (in case the nutrients are added as salts) and / or carrier materials.
About 0.32 wt% of Building Block B based on the total weight of the dairy product, composed of 1.2% iron , 1% zinc, 0.02% manganese, 0.12% copper, 1.75% glucose syrup solids, 0.02% iodine, 0.005% selenium, the remainder being comprised of counter ions ( in case the nutrients are added as salts) and/or carrier materials;About 0.32 wt% of Building Block B based on the total weight of the dairy product, composed of 1.2% iron, 1% zinc, 0.02% manganese, 0.12% copper, 1.75% glucose syrup solids, 0.02% iodine, 0.005% selenium, the remainder being comprised of counter ions and / or carrier materials;
About 0.42 wt% of Building Block C based on the total weight of the dairy product, composed of 23.8% potassium, 25.5% glucose syrup solids, 5% sodium, 13% chloride, the remainder being comprised of counter ions (in case the nutrients are added as salts) and/or carrier materials;About 0.42 wt% of Building Block C based on the total weight of the dairy product, composed of 23.8% potassium, 25.5% glucose syrup solids, 5% sodium, 13% chloride, the remainder being comprised of counter ions (in case the nutrients are added as salts) and / or carrier materials;
And about 6.36 wt% of optional ingredients based on the total weight of the dairy product; 4% GOS powder (70% premix), 1% AA powder (10% premix), 1% DHA powder (12% premix), 0.25% L-phenylalanine (50% premix), 0.1% nucleotides, 0.01% L-tryptophan.And about 6.36 wt% or optional ingredients based on the total weight of the dairy product; 4% GOS powder (70% premix), 1% AA powder (10% premix), 1% DHA powder (12% premix), 0.25% L-phenylalanine (50% premix), 0.1% nucleotides, 0.01% L-tryptophan .
This example shows an embodiment of the invention. It will be understood that other examples can also be envisaged in accordance with the present invention. The present invention is by no means limited to the above described preferred embodiments thereof. The rights sought are defined by the following claims, within the scope of which many modifications can be envisaged.This example shows an embodiment of the invention. It will be understood that other examples can also be envisaged in accordance with the present invention. The present invention is by no means limited to the above described preferred expend. The rights sought are defined by the following claims, within the scope of which many modifications can be envisaged.
Claims (16)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL2020159A NL2020159B1 (en) | 2017-12-22 | 2017-12-22 | Method for production of a dairy product and system for composing a dairy product |
EP18839920.8A EP3727001A1 (en) | 2017-12-22 | 2018-12-06 | Method for production of a dairy product and system for composing a dairy product |
PCT/NL2018/050814 WO2019125139A1 (en) | 2017-12-22 | 2018-12-06 | Method for production of a dairy product and system for composing a dairy product |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL2020159A NL2020159B1 (en) | 2017-12-22 | 2017-12-22 | Method for production of a dairy product and system for composing a dairy product |
Publications (1)
Publication Number | Publication Date |
---|---|
NL2020159B1 true NL2020159B1 (en) | 2019-07-01 |
Family
ID=60957419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL2020159A NL2020159B1 (en) | 2017-12-22 | 2017-12-22 | Method for production of a dairy product and system for composing a dairy product |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3727001A1 (en) |
NL (1) | NL2020159B1 (en) |
WO (1) | WO2019125139A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008111942A2 (en) * | 2006-04-18 | 2008-09-18 | Abbott Laboratories | Method of tailoring infant formulas to individual nutritional needs prior to use |
CN101878819A (en) * | 2010-07-20 | 2010-11-10 | 澳优乳业(中国)有限公司 | Baby formula milk powder containing adiponectin and preparation method thereof |
WO2015086174A1 (en) * | 2013-12-12 | 2015-06-18 | Nestec S.A. | Array of age-tailored nutritional formulae with optimum mineral nutrient content |
US20170188617A1 (en) * | 2016-01-04 | 2017-07-06 | Cari Genea Crossley | Infant formula with improved nutritional value and digestive properties |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2013244938B2 (en) * | 2012-04-05 | 2017-06-08 | Société des Produits Nestlé S.A. | Apparatus and method for providing metered amounts of ingredient, especially for a tailored nutrition to infants |
-
2017
- 2017-12-22 NL NL2020159A patent/NL2020159B1/en active
-
2018
- 2018-12-06 EP EP18839920.8A patent/EP3727001A1/en not_active Withdrawn
- 2018-12-06 WO PCT/NL2018/050814 patent/WO2019125139A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008111942A2 (en) * | 2006-04-18 | 2008-09-18 | Abbott Laboratories | Method of tailoring infant formulas to individual nutritional needs prior to use |
CN101878819A (en) * | 2010-07-20 | 2010-11-10 | 澳优乳业(中国)有限公司 | Baby formula milk powder containing adiponectin and preparation method thereof |
WO2015086174A1 (en) * | 2013-12-12 | 2015-06-18 | Nestec S.A. | Array of age-tailored nutritional formulae with optimum mineral nutrient content |
US20170188617A1 (en) * | 2016-01-04 | 2017-07-06 | Cari Genea Crossley | Infant formula with improved nutritional value and digestive properties |
Non-Patent Citations (1)
Title |
---|
DATABASE WPI Week 201119, Derwent World Patents Index; AN 2010-Q17829, XP002778811 * |
Also Published As
Publication number | Publication date |
---|---|
EP3727001A1 (en) | 2020-10-28 |
WO2019125139A1 (en) | 2019-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4317455B2 (en) | Compositions for infant formulas containing large amounts of alpha-lactalbumin | |
JP2014530005A (en) | Powdered nutritional formula containing spray-dried plant protein | |
AU2018102087A6 (en) | Gender specific synthetic nutritional compositions and nutritional systems comprising them | |
AU2018295414A1 (en) | Human milk fortifier | |
CN111405850A (en) | Gender specific synthetic nutritional compositions comprising lycopene and nutritional systems comprising the same | |
RU2683870C1 (en) | Differentiated by gender artificial nutritional compositions and food containing these systems | |
NL2020159B1 (en) | Method for production of a dairy product and system for composing a dairy product | |
US20200315236A1 (en) | Synthetic nutritional compositions tailored for infants of specific ages, and nutritional systems comprising them | |
RU2710158C1 (en) | Gender specific synthetic nutrient compositions and feeding systems containing thereof | |
CN104981170A (en) | Stabilized liquid nutritionals including insoluble calcium salts | |
US9693577B2 (en) | Method of preparing a nutritional powder comprising spray dried HMB | |
AU2015101943A4 (en) | Gender specific synthetic nutritional compositions and nutritional systems comprising them. | |
WO2005110123A1 (en) | Stable nutritional powder containing ascorbyl palmitate | |
WO2015073843A1 (en) | Better tasting nutritional powders | |
CN112770645A (en) | Gender specific synthetic nutritional compositions and nutritional systems comprising same | |
AU2018102083A6 (en) | Gender specific synthetic nutritional compositions and nutritional systems comprising them | |
WO2017054107A1 (en) | Gender specific synthetic nutritional compositions and nutritional systems comprising them | |
CN110996684A (en) | Gender specific synthetic nutritional compositions and nutritional system products comprising the same | |
US20150352071A1 (en) | Methods for reducing muscle soreness after exercise using beta-hydroxy-beta-methylbutyrate | |
CN110996940A (en) | Synthetic nutritional compositions tailored for infants of a particular age and nutritional system products comprising the same | |
WO2017054109A1 (en) | Gender specific synthetic nutritional compositions and nutritional systems comprising them |